R1 RCM Inc (NASDAQ:RCM) Given Consensus Rating of “Buy” by Brokerages

R1 RCM Inc (NASDAQ:RCM) has earned a consensus recommendation of “Buy” from the seven ratings firms that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $13.40.

A number of equities analysts have recently issued reports on the stock. ValuEngine lowered shares of R1 RCM from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. BidaskClub lowered shares of R1 RCM from a “sell” rating to a “strong sell” rating in a research report on Tuesday, October 1st. Zacks Investment Research upgraded shares of R1 RCM from a “hold” rating to a “buy” rating and set a $10.00 target price on the stock in a research report on Wednesday. Finally, Robert W. Baird set a $14.00 target price on shares of R1 RCM and gave the stock a “buy” rating in a research report on Thursday, September 12th.

Shares of RCM stock traded up $0.31 during trading hours on Friday, reaching $9.51. 51,757 shares of the company were exchanged, compared to its average volume of 1,297,998. R1 RCM has a fifty-two week low of $7.10 and a fifty-two week high of $13.19. The stock’s fifty day moving average is $10.48 and its two-hundred day moving average is $11.37. The company has a market cap of $1.05 billion, a price-to-earnings ratio of -29.59 and a beta of 0.10. The company has a debt-to-equity ratio of 106.30, a current ratio of 0.90 and a quick ratio of 0.90.

R1 RCM (NASDAQ:RCM) last announced its earnings results on Tuesday, August 6th. The financial services provider reported ($0.09) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.01) by ($0.08). R1 RCM had a negative return on equity of 249.01% and a negative net margin of 2.22%. The company had revenue of $295.00 million for the quarter, compared to analyst estimates of $294.11 million. During the same quarter in the previous year, the company posted ($0.07) earnings per share. R1 RCM’s revenue for the quarter was up 41.9% on a year-over-year basis. On average, research analysts anticipate that R1 RCM will post 0.06 earnings per share for the current year.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Aperio Group LLC bought a new stake in shares of R1 RCM during the second quarter worth approximately $127,000. NumerixS Investment Technologies Inc raised its stake in shares of R1 RCM by 73.3% during the second quarter. NumerixS Investment Technologies Inc now owns 10,400 shares of the financial services provider’s stock worth $131,000 after buying an additional 4,400 shares during the last quarter. Los Angeles Capital Management & Equity Research Inc. bought a new stake in shares of R1 RCM during the second quarter worth approximately $139,000. SG Americas Securities LLC bought a new stake in shares of R1 RCM during the first quarter worth approximately $142,000. Finally, Bank of Montreal Can raised its stake in shares of R1 RCM by 179.5% during the second quarter. Bank of Montreal Can now owns 13,308 shares of the financial services provider’s stock worth $168,000 after buying an additional 8,547 shares during the last quarter. 70.75% of the stock is owned by institutional investors and hedge funds.

R1 RCM Company Profile

R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.

Featured Story: What is the Quick Ratio?

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.